Overview

* Oscar Health's ( OSCR ) preliminary Q2 net loss at $228 mln, driven by ACA risk scores

* Co revises 2025 guidance; expects $12.0 bln to $12.2 bln revenue

* Adjusted EBITDA for Q2 misses analyst expectations, per LSEG data

Outlook

* Oscar Health ( OSCR ) revises 2025 revenue guidance to $12.0 bln-$12.2 bln

* Company expects 2025 medical loss ratio of 86.0%-87.0%

* Oscar anticipates 2025 operational loss of $200 mln-$300 mln

Result Drivers

* HIGHER ACA RISK SCORES - Oscar attributes increased net loss to higher ACA Marketplace risk scores

* ELEVATED UTILIZATION - Member utilization remained elevated, impacting financial results

* COST TRENDS MODERATION - Cost trends moderated in Q2 compared to Q1, per company statement

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Net -$228

Income mln

Q2 Miss -$120 $116.90

Adjusted mln mln (6

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 5 "sell" or "strong sell"

* The average consensus recommendation for the life & health insurance peer group is "buy."

* Wall Street's median 12-month price target for Oscar Health Inc ( OSCR ) is $11.00, about 23.8% below its July 21 closing price of $13.62

* The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)